AVIEW LCS vs Eko Murmur Analysis Software (EMAS)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Coreline Soft
VS

AI Verdict

AVIEW LCS specializes in AI-powered analysis of CT scans for lung cancer screening, COPD, and coronary artery calcification, optimizing radiology workflows. Eko Murmur Analysis Software, conversely, integrates with digital stethoscopes to detect and differentiate heart murmurs and AFib from heart sound and ECG data, supporting point-of-care diagnostics. While both contribute to cardiopulmonary assessment, they utilize distinct data modalities and target different diagnostic stages.

Choose AVIEW LCS if…

Choose AVIEW LCS if your practice requires an advanced, AI-driven solution for comprehensive cardiopulmonary assessment directly from low-dose CT scans. This tool is ideal for radiology departments and oncology programs needing automated lung nodule detection, Lung-RADS classification, and coronary artery calcification scoring to streamline lung cancer screening workflows and monitor disease progression.

View AVIEW LCS →

Choose Eko Murmur Analysis Software (EMAS) if…

Choose Eko Murmur Analysis Software (EMAS) if you need an immediate, AI-powered clinical decision support tool for detecting and differentiating heart murmurs during patient examinations. This solution is best suited for clinicians in primary care, pediatrics, or cardiology who utilize Eko digital stethoscopes and require real-time analysis of heart sounds to aid in early detection of cardiac conditions.

View Eko Murmur Analysis Software (EMAS) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature AVIEW LCS Eko Murmur Analysis Software (EMAS)
Pricing Subscription or one-off payment Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales.
Deployment Cloud-based, Hybrid solution, Locally on dedicated hardware, Locally virtualized (virtual machine, Docker) Cloud-based, Mobile App
BAA Available Unknown Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) offers a highly intuitive and portable mobile-first experience, integrating seamlessly with digital stethoscopes for point-of-care diagnostics. Its mobile app is described as simple and well-designed, with quick setup and easy recording and sharing features. While AVIEW LCS integrates well into complex radiology workflows, EMAS's direct mobile app interface and immediate accessibility for individual clinicians give it an edge in overall usability.

Clinical Value

AVIEW LCS

AVIEW LCS provides a broader and more comprehensive clinical assessment from a single low-dose CT scan, simultaneously evaluating for lung cancer, COPD, and coronary artery calcification. This '3-in-1' approach streamlines diagnostics, enhances diagnostic accuracy, and identifies multiple critical health risks. EMAS, while highly effective and FDA-cleared for heart murmur detection and differentiation, is more specialized in its diagnostic scope.

Pricing & Value

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) offers transparent pricing, including a free tier for basic AI analysis with its mobile app, providing immediate value and accessibility. Its tiered subscription model allows users to scale features based on their needs. AVIEW LCS, as an enterprise solution, lacks public pricing information, requiring direct contact for quotes.

Enterprise Readiness

AVIEW LCS

AVIEW LCS demonstrates superior enterprise readiness with its flexible deployment options (cloud, hybrid, local hardware, virtualized) and deep integration capabilities with existing hospital IT infrastructure like PACS/RIS. It also features a platform (AVIEW HUB) for managing multi-site workflows and structured reporting, which are critical for large healthcare organizations. EMAS, while EHR compatible, is primarily mobile-app driven, offering less flexibility for complex enterprise IT environments.

Innovation

Tie

Both tools showcase significant innovation. AVIEW LCS is innovative for its integrated, multi-disease analysis (lung cancer, COPD, CAC) from a single CT scan, offering a holistic diagnostic approach and automated nodule comparison for follow-up. EMAS innovates by transforming the traditional stethoscope into an AI-powered diagnostic tool for point-of-care murmur detection and differentiation, significantly enhancing early disease identification. Each advances healthcare AI in distinct and impactful ways.

Support & Docs

Eko Murmur Analysis Software (EMAS)

Eko Murmur Analysis Software (EMAS) provides more transparent and readily available information regarding its support channels, including a dedicated Help Center, FAQs, email, phone, and chat support with specified hours and response times for enterprise clients. While AVIEW LCS, as an enterprise solution, is expected to offer robust support, explicit details are not as publicly documented as for EMAS.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature AVIEW LCS Eko Murmur Analysis Software (EMAS)
Name AVIEW LCS Eko Murmur Analysis Software (EMAS)
Company Coreline Soft Co. Eko Devices
Primary Focus AI-powered solution for the detection and analysis of lung nodules, lung cancer, COPD, and coronary artery calcification from CT scans. AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients.
Target Specialties Cardiology, Oncology, Pulmonology, Radiology Cardiology, Internal Medicine, Pediatrics
Integration Capabilities Integration with PACS/RIS and third-party platforms Integrates with Eko digital stethoscopes; Mobile app for recording, playback, annotation, and saving; Wireless Bluetooth connectivity to mobile devices; PDF report generation and sharing (EHR compatible)

Videos

Demos, reviews, and walkthroughs featuring AVIEW LCS and Eko Murmur Analysis Software (EMAS).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

AVIEW LCS is an AI-powered solution for the detection and analysis of lung nodules, COPD, and coronary artery calcification from low-dose CT scans, primarily for specialties like Radiology, Pulmonology, Oncology, and Cardiology. Eko Murmur Analysis Software (EMAS) is an FDA-cleared AI tool that integrates with Eko digital stethoscopes to detect and differentiate heart murmurs in adult and pediatric patients, providing clinical decision support for early detection of heart and lung disease, serving Cardiology, Internal Medicine, and Pediatrics.
AVIEW LCS requires low-dose CT scan data for its analysis of lung and cardiac conditions. Eko Murmur Analysis Software (EMAS) integrates with Eko digital stethoscopes (e.g., CORE 500, DUO, CORE) to analyze heart sound (PCG) and optional ECG data.
AVIEW LCS is designed for integration with PACS/RIS and other third-party platforms, generating comprehensive automated reports. Eko Murmur Analysis Software (EMAS) integrates with Eko digital stethoscopes and allows for PDF report generation and sharing, which is EHR compatible.
While distinct, both tools have cardiology applications; AVIEW LCS provides coronary artery calcification (CAC) scoring from CT scans. EMAS focuses on detecting and differentiating heart murmurs and AFib (with CORE 500) using stethoscope data.

Backers

Who funded each tool's parent company.

Eko Murmur Analysis Software (EMAS)

AI Tool Finder
AI-powered search. Results may not be comprehensive.